Machine Learning Times
EXCLUSIVE HIGHLIGHTS
Jev Fever: Predictive AI Is Superhot Again
  Originally published in Forbes The more AI changes, the...
GenAI Owns the Hype, but Predictive AI Is Thriving
  EDITOR’S NOTE: This article is adapted from the...
The Data Disconnect: A Key Challenge for Machine Learning Deployment
  EDITOR’S NOTE: This article is excerpted from The...
A Brief History of Why Machine Learning Projects Stall
  EDITOR’S NOTE: This is the preface to The...
SHARE THIS:

11 years ago
Wise Practitioner – Predictive Analytics Interview Series: Scott Jelinsky of Pfizer, Inc.

 In anticipation of his upcoming conference presentation at Predictive Analytics World for Healthcare Boston, Sept 27-Oct 1, 2015, we asked Scott Jelinksy, Principal Research Scientist at Pfizer, Inc., a few questions about incorporating predictive analytics into healthcare. Catch a glimpse of his presentation, Crowdsourcing Predictive Analytics to Enhance Clinical Trial Design, and see what’s in store for the second annual PAW Healthcare conference in Boston. Q: In your work with predictive analytics, what area of healthcare are you focused on? A: We use predictive analytics to support a variety of different areas of health care, but our primary interest is

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.

Comments are closed.